Site Search

Antimicrobial Resistance Accelerator

Parkinson disease with mild cognition impairment treated with nicotinic agonist drug

Saracatinib trial to prevent FOP

Novel Gram-negative antibiotic now

Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments

Cardiomyopathy in type 2 diabetes mellitus

Integrated immunoprofiling of large adaptive cancer patients cohorts